Literature DB >> 21579374

(4-Carbamoylphen-yl)boronic acid.

Margarita D Apostolova, Rositsa P Nikolova, Boris L Shivachev.   

Abstract

In the title compound, C(7)H(8)BNO(3), the mol-ecule lies on an inversion center leading to a statistical disorder of the B(OH)(2) and CONH(2) groups. In the crystal structure, mol-ecules are linked by N-H⋯O and O-H⋯O hydrogen bonds, forming sheets parallel to the bc plane. The B(OH)(2) and CONH(2) groups are twisted out of the mean plane of the benzene ring by 23.9 (5) and 24.6 (6)°, respectively.

Entities:  

Year:  2010        PMID: 21579374      PMCID: PMC2979401          DOI: 10.1107/S1600536810014789

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For general background to the use of boronic acids in organic synthesis, as pharmaceutical agents and in crystal engineering see: Miyaura & Suzuki (1995 ▶); Suzuki (1999 ▶); Adams & Kauffman (2004 ▶); Barth et al. (2005 ▶); Minkkilä et al. (2008 ▶); Maly et al. (2006 ▶); Desiraju (1995 ▶); James et al. (2006 ▶).. For related structures, see: Cobbledick & Small (1972 ▶); Rodríguez-Cuamatzi et al. (2004 ▶). For hydrogen-bond motifs, see: Bernstein et al. (1995 ▶).

Experimental

Crystal data

C7H8BNO3 M = 164.95 Triclinic, a = 4.997 (2) Å b = 5.351 (2) Å c = 7.2967 (16) Å α = 103.912 (13)° β = 98.69 (2)° γ = 93.136 (14)° V = 186.36 (11) Å3 Z = 1 Mo Kα radiation μ = 0.11 mm−1 T = 290 K 0.27 × 0.25 × 0.25 mm

Data collection

Enraf–Nonius CAD-4 diffractometer 2155 measured reflections 1078 independent reflections 755 reflections with I > 2σ(I) R int = 0.054 3 standard reflections every 120 min intensity decay: 2%

Refinement

R[F 2 > 2σ(F 2)] = 0.053 wR(F 2) = 0.148 S = 1.03 1078 reflections 75 parameters 88 restraints H-atom parameters constrained Δρmax = 0.28 e Å−3 Δρmin = −0.23 e Å−3 Data collection: CAD-4 EXPRESS (Enraf–Nonius, 1994 ▶); cell refinement: CAD-4 EXPRESS; data reduction: XCAD4 (Harms & Wocadlo, 1995 ▶); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: ORTEP-3 for Windows (Farrugia, 1997 ▶) and Mercury (Bruno et al., 2002 ▶); software used to prepare material for publication: WinGX (Farrugia, 1999 ▶). Crystal structure: contains datablocks I, global. DOI: 10.1107/S1600536810014789/lh2998sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536810014789/lh2998Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C7H8BNO3Z = 1
Mr = 164.95F(000) = 86
Triclinic, P1Dx = 1.470 Mg m3
Hall symbol: -P 1Melting point: not measured K
a = 4.997 (2) ÅMo Kα radiation, λ = 0.71073 Å
b = 5.351 (2) ÅCell parameters from 22 reflections
c = 7.2967 (16) Åθ = 18.0–19.8°
α = 103.912 (13)°µ = 0.11 mm1
β = 98.69 (2)°T = 290 K
γ = 93.136 (14)°Prismatic, colorless
V = 186.36 (11) Å30.27 × 0.25 × 0.25 mm
Enraf–Nonius CAD-4 diffractometerRint = 0.054
Radiation source: fine-focus sealed tubeθmax = 30.0°, θmin = 2.9°
graphiteh = −7→7
Non–profiled ω/2θ scansk = −7→7
2155 measured reflectionsl = −10→10
1078 independent reflections3 standard reflections every 120 min
755 reflections with I > 2σ(I) intensity decay: 2%
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.053Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.148H-atom parameters constrained
S = 1.03w = 1/[σ2(Fo2) + (0.0786P)2 + 0.0033P] where P = (Fo2 + 2Fc2)/3
1078 reflections(Δ/σ)max = 0.001
75 parametersΔρmax = 0.28 e Å3
88 restraintsΔρmin = −0.23 e Å3
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/UeqOcc. (<1)
B1−0.001 (3)−0.298 (2)0.2892 (18)0.0268 (10)0.50
O1−0.243 (3)−0.393 (3)0.318 (3)0.0399 (19)0.50
H1−0.2184−0.45840.40920.060*0.50
O20.236 (2)−0.334 (2)0.404 (2)0.0351 (15)0.50
H2A0.3669−0.31580.35100.053*0.50
C10.0096 (17)0.113 (2)−0.1593 (16)0.0246 (10)0.50
C2−0.2061 (18)−0.068 (2)−0.1647 (17)0.0314 (10)0.50
H2−0.3512−0.1021−0.26610.038*0.50
C3−0.207 (2)−0.197 (2)−0.0217 (17)0.0314 (10)0.50
H3−0.3529−0.3166−0.02820.038*0.50
C40.0069 (18)−0.150 (2)0.1318 (16)0.0246 (10)0.50
C50.2219 (19)0.029 (2)0.1375 (17)0.0314 (10)0.50
H50.36700.06340.23890.038*0.50
C60.223 (2)0.158 (2)−0.0057 (17)0.0314 (10)0.50
H60.36850.27760.00100.038*0.50
C70.016 (2)0.256 (2)−0.3128 (15)0.0268 (10)0.50
O30.237 (3)0.341 (3)−0.344 (3)0.0399 (19)0.50
N1−0.212 (3)0.283 (3)−0.415 (3)0.0351 (15)0.50
H1A−0.21120.3606−0.50510.042*0.50
H1B−0.36310.2237−0.39160.042*0.50
U11U22U33U12U13U23
B10.0340 (13)0.027 (3)0.024 (2)0.0062 (15)0.0098 (12)0.011 (2)
O10.0295 (7)0.054 (5)0.048 (4)0.002 (2)0.0081 (18)0.035 (4)
O20.0282 (18)0.046 (4)0.0412 (16)0.006 (2)0.0081 (15)0.029 (3)
C10.0301 (11)0.028 (3)0.020 (3)0.0076 (11)0.0089 (11)0.0097 (19)
C20.0331 (11)0.038 (3)0.024 (3)−0.0005 (12)−0.0004 (12)0.0137 (19)
C30.0329 (11)0.034 (3)0.030 (3)−0.0018 (12)0.0048 (12)0.015 (2)
C40.0301 (11)0.028 (3)0.020 (3)0.0076 (11)0.0089 (11)0.0097 (19)
C50.0331 (11)0.038 (3)0.024 (3)−0.0005 (12)−0.0004 (12)0.0137 (19)
C60.0329 (11)0.034 (3)0.030 (3)−0.0018 (12)0.0048 (12)0.015 (2)
C70.0340 (13)0.027 (3)0.024 (2)0.0062 (15)0.0098 (12)0.011 (2)
O30.0295 (7)0.054 (5)0.048 (4)0.002 (2)0.0081 (18)0.035 (4)
N10.0282 (18)0.046 (4)0.0412 (16)0.006 (2)0.0081 (15)0.029 (3)
B1—O11.351 (8)C3—C41.391 (8)
B1—O21.393 (8)C3—H30.9300
B1—C41.546 (6)C4—C51.391 (8)
O1—H10.8200C5—C61.384 (8)
O2—H2A0.8200C5—H50.9300
C1—C61.388 (8)C6—H60.9300
C1—C21.397 (8)C7—O31.246 (7)
C1—C71.505 (6)C7—N11.298 (7)
C2—C31.384 (8)N1—H1A0.8600
C2—H20.9300N1—H1B0.8600
O1—B1—O2118.9 (15)C5—C4—B1122.2 (8)
O1—B1—C4119.4 (13)C6—C5—C4120.8 (5)
O2—B1—C4121.6 (12)C6—C5—H5119.6
C6—C1—C2117.8 (5)C4—C5—H5119.6
C6—C1—C7120.0 (7)C5—C6—C1121.2 (6)
C2—C1—C7122.2 (7)C5—C6—H6119.4
C3—C2—C1121.1 (5)C1—C6—H6119.4
C3—C2—H2119.5O3—C7—N1120.8 (16)
C1—C2—H2119.5O3—C7—C1120.4 (13)
C2—C3—C4120.8 (5)N1—C7—C1118.8 (13)
C2—C3—H3119.6C7—N1—H1A120.0
C4—C3—H3119.6C7—N1—H1B120.0
C3—C4—C5118.2 (5)H1A—N1—H1B120.0
C3—C4—B1119.5 (8)
D—H···AD—HH···AD···AD—H···A
O1—H1···O2i0.821.962.77 (2)167
O2—H2A···O1ii0.822.052.79 (2)149
O2—H2A···O3iii0.822.002.73 (2)149
N1—H1A···O3iv0.862.142.97 (3)160.7
N1—H1B···O1v0.862.302.97 (2)135.7
N1—H1B···O3vi0.862.182.90 (2)140.8
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
O1—H1⋯O2i0.821.962.77 (2)167
O2—H2A⋯O1ii0.822.052.79 (2)149
O2—H2A⋯O3iii0.822.002.73 (2)149
N1—H1A⋯O3iv0.862.142.97 (3)160.7
N1—H1B⋯O1v0.862.302.97 (2)135.7
N1—H1B⋯O3vi0.862.182.90 (2)140.8

Symmetry codes: (i) ; (ii) ; (iii) ; (iv) ; (v) ; (vi) .

  5 in total

1.  New software for searching the Cambridge Structural Database and visualizing crystal structures.

Authors:  Ian J Bruno; Jason C Cole; Paul R Edgington; Magnus Kessler; Clare F Macrae; Patrick McCabe; Jonathan Pearson; Robin Taylor
Journal:  Acta Crystallogr B       Date:  2002-05-29

2.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

3.  Discovery of boronic acids as novel and potent inhibitors of fatty acid amide hydrolase.

Authors:  Anna Minkkilä; Susanna M Saario; Heikki Käsnänen; Jukka Leppänen; Antti Poso; Tapio Nevalainen
Journal:  J Med Chem       Date:  2008-11-27       Impact factor: 7.446

Review 4.  Boron neutron capture therapy of cancer: current status and future prospects.

Authors:  Rolf F Barth; Jeffrey A Coderre; M Graça H Vicente; Thomas E Blue
Journal:  Clin Cancer Res       Date:  2005-06-01       Impact factor: 12.531

Review 5.  Development of the proteasome inhibitor Velcade (Bortezomib).

Authors:  Julian Adams; Michael Kauffman
Journal:  Cancer Invest       Date:  2004       Impact factor: 2.176

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.